Pediatric Laser Acupuncture and Renal Biopsy
Keywords
Abstract
Description
At University of California San Francisco, there are approximately 100 pediatric renal biopsies per year. All of these patients receive sedation, which is prescribed and supervised by the pediatric pain and palliative care team, with either ketamine or fentanyl and versed. Child life is involved; however, many children still experience anxiety and/or pain with the procedure. Use of a modality such as aculaser which may decrease these symptoms could enhance their experience.
The term "laser" stands for light amplification by stimulated emission of radiation. In laser acupuncture, a low power, cold light produced by a low-level laser diode is used to stimulate an acupuncture point. As it is non-invasive, laser acupuncture is thought to be safer than needle acupuncture, especially in the setting of patients with blood-borne infectious diseases. In a systematic review analyzing the evidence to support the effectiveness of laser acupuncture, randomized control trials in which adults with soft tissue injury, acute or chronic pain condition, or any systemic illness were included. This review reports moderate level of evidence for treatment of myofascial pain and post-operative nausea/vomiting and limited evidence of the clinical effectiveness of treating chronic tension headaches. Of note, no complications of the use of aculaser were reported in this review (1).
1. Baxter GD, Bleakley C, McDonough S. Clinical effectiveness of laser acupuncture: a systematic review. J Acupunct Meridian Stud. 2008 Dec;1(2):65-82.
Dates
| Last Verified: | 12/31/2019 |
| First Submitted: | 06/12/2013 |
| Estimated Enrollment Submitted: | 06/12/2013 |
| First Posted: | 06/17/2013 |
| Last Update Submitted: | 01/12/2020 |
| Last Update Posted: | 01/21/2020 |
| Date of first submitted results: | 10/23/2016 |
| Date of first submitted QC results: | 01/12/2020 |
| Date of first posted results: | 01/21/2020 |
| Actual Study Start Date: | 06/30/2013 |
| Estimated Primary Completion Date: | 10/31/2015 |
| Estimated Study Completion Date: | 10/31/2015 |
Condition or disease
Intervention/treatment
Device: Aculaser applied to kidney points
Device: Aculaser applied to sham points
Phase
Arm Groups
| Arm | Intervention/treatment |
|---|---|
| Sham Comparator: Aculaser applied to sham points The patient will receive aculaser, performed by licensed acupuncturist, to "sham" acupuncture sites. In addition, the patient will still receive standard pain control protocols with anesthetic medications like lidocaine plus ketamine or fentanyl and versed during the biopsy, along with pain management after the procedure. | Device: Aculaser applied to sham points The patient will receive aculaser, performed by licensed acupuncturist, to "sham" acupuncture sites. In addition, the patient will still receive standard pain control protocols with anesthetic medications like lidocaine plus ketamine or fentanyl and versed during the biopsy, along with pain management after the procedure. |
| Experimental: Aculaser applied to kidney points The patient will receive aculaser, performed by licensed acupuncturist, to known kidney acupuncture sites. In addition, the patient will still receive standard pain control protocols with anesthetic medications like lidocaine plus ketamine or fentanyl and versed during the biopsy, along with pain management after the procedure. | Device: Aculaser applied to kidney points The patient will receive aculaser, performed by licensed acupuncturist, to known kidney acupuncture sites. In addition, the patient will still receive standard pain control protocols with anesthetic medications like lidocaine plus ketamine or fentanyl and versed during the biopsy, along with pain management after the procedure. |
Eligibility Criteria
| Ages Eligible for Study | 7 Years To 7 Years |
| Sexes Eligible for Study | All |
| Accepts Healthy Volunteers | Yes |
| Criteria | Inclusion Criteria: - older than 6 years old - admitted for a transplant or native kidney biopsy performed by pediatric nephrology Exclusion Criteria: - Prisoners - Pregnant females - Those who are unable to participate with the visual analog scale |
Outcome
Primary Outcome Measures
1. Patient Pain/Anxiety [1 day]
Secondary Outcome Measures
1. Parent Perception of Patient Pain Report [1 day]
